Announced Mon, 29 Jun · 09:59 IST
Trading window closed from July 1 ahead of Q1 results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹75.08
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+4.0+6.1+8.2+10.4+12.6+17.1+37.1———
Up moveDown movePending
AI summary
Parmax Pharma has closed its trading window for designated persons from July 1, 2026 until 48 hours after Q1 FY27 financial results (quarter ending June 30, 2026) are declared. This is per SEBI Insider Trading Regulations, 2015 and the company's code of conduct. The board meeting date to approve the results will be announced later. Designated persons cannot trade in the company's securities during this period.
Likely market impact
Insiders cannot trade until results are declared. No direct price impact, but signals an upcoming Q1 earnings announcement.